Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab
LungOI Is Among The First AI-based Tests To Receive a Medicare Payment Rate. Imagene, a pioneer in AI-based precision oncology, is pleased to announce the...
Imagene Increases Accessibility of Rapid AI-Based Biomarker Profiling Through Integration With Sectra
ImageneOI is the first NSCLC genomic profiling AI tool on the Sectra Amplifier Marketplace. Imagene, a pioneer in AI-based precision oncology, today announced the integration...
Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling
Rapid NSCLC Biomarker Test already demonstrated its significant impact and clinical benefits as part of a lung cancer clinical study. Imagene, an emerging leader in...
Hoag Hospital and Imagene Partner to Empower Rapid Cancer Diagnosis for Personalized Cancer Care
Leveraging AI-based molecular profiling from a digitized biopsy image to enable physicians to gain immediate oncology intelligence. Hoag, the largest community-based healthcare system in southern...
Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology
The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report. Imagene, an emerging leader...
Imagene Welcomes World-Leading Oncologists at the Forefront of Precision Oncology to Its Scientific Advisory Board
Visionaries and Experts, Each Having Played a Historical Role in Advancing Precision Oncology Into Current Clinical Practice - Imagene, a pioneering leader in AI-based molecular...
Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation
A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patientsTEL AVIV, ISRAEL / ACCESSWIRE / July 26, 2023 /...
Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation
A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients Imagene, an emerging leader in AI-based precision oncology, is...